Skip to main content Scroll Top
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
Most Viewed Posts
Clear Filters
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
1 April 2026
REGEnLIFE cures inflammatory brain diseases with light
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
Photobiomodulation: light to treat Alzheimer’s disease
Photobiomodulation: light to treat Alzheimer’s disease
2 July 2024
1 December 2019

The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis

12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019, San Diego
Read the article

Guillaume Blivet, Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Jacques Touchon.

Share this article